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Introduction
Neural tube defects (NTDs) have an incidence of 1–2 per
1,000 births and are considered to be a heterogeneous
condition resulting from failure of normal neural tube
closure between the third and fourth week of embry-
onic development. The three common types of NTDs
are anencephaly, spina bifida, and encephalocele. The
uncommon types of NTDs include amniotic band syn-
drome, limb–body wall complex (LBWC), cloacal exstro-
phy or omphalocele-exstrophy-imperforate anus-spinal
defects (OEIS) complex, and other types of spinal abnor-
malities. The incidence of NTDs varies with race, geo-
graphic variation, socioeconomic classes, nutritional
status, and multiple predisposing factors such as single
gene disorders, chromosomal abnormalities, teratogens,
maternal diabetes, family history of NTDs and polymor-
phisms in the genes of folate metabolism [1]. There is
considerable evidence that genetics and environmental
factors contribute to the etiology of NTDs. Fetuses with
NTDs may be associated with syndromes, disorders,
and maternal and fetal risk factors.
Omphalocele
Calzolari et al [2] proposed that omphalocele and
NTDs are related congenital anomalies by the findings
of a tendency for omphalocele to be associated with
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anencephaly and/or spina bifida. Folate-related genes
play an important part in the susceptibility to NTDs.
In particular, the thermolabile variant of the methy-
lenetetrafolate reductase gene (MTHFR 677C T) has
been shown to be a risk factor of NTDs. Mills et al [3]
found a significant association between MTHFR 677C
T and omphalocele. Mills et al [3] hypothesized that
folate-related genes play a role in the etiology of
omphalocele and suggested that folic acid-containing
multivitamins may prevent omphalocele.
Omphalocele-Exstrophy-Imperforate
anus-Spinal defects (OEIS) Complex
OEIS complex (OMIM 258040) arises from a single
localized defect in the early development of the meso-
derm that will later contribute to infraumbilical mes-
enchyme, cloacal septum and caudal vertebrae. The
incidence of OEIS complex has been reported to range
between 1/200,000 and 1/250,000 among live births
[4]. OEIS complex, also known as ectopia cloacae, vesi-
cointestinal fissure, exstrophia splanchnica or cloacal
exstrophy, was named by Carey et al [5] to describe the
combination of omphalocele, exstrophy of the bladder,
an imperforate anus and spinal defects. This multisys-
tem malformation represents the most severe form of the
exstrophy–epispadias sequence, ranging from phallic
separation with epispadias, pubic diastasis, bladder
exstrophy, cloacal exstrophy to OEIS complex. Most
cases of OEIS complex occur spontaneously. There are
reports of recurrence in siblings and concurrent occur-
rence in monozygotic twins, suggesting a genetic con-
tribution to the pathogenesis of OEIS complex [6–8].
Another explanation for the higher reported incidence
of OEIS complex in monozygotic twins is that twinning
formation with duplication of the organizing center
within a single embryonic disc may disrupt the caudal
eminence or its derivatives and increase the risk of meso-
dermal insufficiency resulting in failure of complete de-
velopment of the cloacal membrane [8–9]. However,
there are reports of monozygotic twins discordant for
OEIS complex, suggesting a non-genetic etiology for OEIS
complex [7,8]. The non-genetic etiology of OEIS complex
includes uterine vascular pathogenesis, uteroplacental
vascular insufficiency, in vitro fertilization, multiple ges-
tation, trauma to the uterus or uterine vessels, and ab-
normal placentation [8,10,11]. OEIS complex or cloacal
exstrophy has been shown to be associated with prenatal
exposure to diazepam, in vitro fertilization and chorionic
villus sampling, Opitz BBB syndrome, Goltz syndrome,
trisomies 13, 18 and 21, triple X syndrome, oculoauricu-
lovertebral syndrome, frontonasal dysplasia, mutations
in mitochondrial 12S rRNA, and mutations in homeo-
box genes such as HLXB9, 3q12.2–q13.2 deletion 
and 9q34.1–qter deletion [5,10,12–20]. Maternal α-
fetoprotein is elevated in OEIS complex. Prenatal diag-
nosis of OEIS complex can be made using ultrasound.
The characteristic sonographic findings of OEIS complex
include nuchal thickening, omphalocele, lumbosacral
myelomeningocele, failure to visualize the bladder and
external genitalia, and limb defects such as clubfoot or
a missing lower limb [8,10,11,16,21–31].
Pentalogy of Cantrell
The incidence of pentalogy of Cantrell has been esti-
mated to be 1/65,000 among live births [32]. Cantrell
et al [33] first described a specific combination of
congenital defects with the following full pentalogy:
(1) a midline supraumbilical abdominal wall defect,
(2) a defect of the lower sternum, (3) a defect of the
diaphragmatic pericardium, (4) a deficiency of the ante-
rior diaphragm, and (5) congenital cardiac anomalies.
Although incomplete expression of the syndrome is
well recognized, the full pentalogy is a rare occurrence.
Pentalogy of Cantrell is the most severe expression of
anomalies in the ventral midline developmental field
and is thought to be the result of mechanical teratogen-
esis [34], major gene mutation [35,36], chromosomal
abnormalities, particularly trisomy 18 [37,38], and
disruptive vascular defects [39]. Carmi and Boughman
[40] reported that a cleft lip with or without a cleft
palate, together with encephalocele, tended to be
especially associated with ventral midline anomalies
within the spectrum of pentalogy of Cantrell. Toyama
[41], Spitz et al [42] and Ghidini et al [43] reviewed
the literature and found that craniofacial malforma-
tions such as anencephaly, meningocele, encephalocele
and hydrocephalus were associated with pentalogy of
Cantrell. Other midline anomalies such as sirenomelia
[39], frontonasal dysplasia [44], exencephaly [45–48],
craniorachischisis [49], spina bifida [50] and a small
posterior encephalocele with myelomeningocele [51]
have also been reported to be associated with penta-
logy of Cantrell. These findings support the proposal
by Carmi and Boughman [40] that pentalogy of
Cantrell is included among the defects of the midline
developmental field.
Amniotic Band Sequence (ABS)
ABS consists of a group of sporadic abnormalities
characterized by congenital ring constrictions or
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amputation of digits and limbs, terminal digital fusion
(pseudosyndactyly), talipes, and multiple craniofacial,
visceral and body wall defects. Cranial defects associ-
ated with ABS include hydrocephalus, microcephaly,
asymmetric encephalocele, meningocele, exencephaly,
acrania, acalvaria, and anencephaly. Facial anomalies
include cleft lip (usually bilateral), bizarre midfacial
clefts, nasal deformity, bony orbital clefts, hypertelorism,
eye-lid colobomas, ptosis, ectropion, lacrimal outflow
obstruction, and corneal opacities. ABS is usually a
sporadic event, although a few reported cases have
been associated with teratogens such as methadone
and lysergic acid diethylamide [52]. Familial ABS is
due to hereditary connective tissue abnormalities such
as Ehlers-Danlos syndrome type IV and osteogenesis
imperfecta [52].
Limb–Body Wall Complex (LBWC)
LBWC describes a heterogeneous group of fetal malfor-
mations, including lateral body–wall defects and limb
reduction anomalies [32,53–59]. Cases of LBWC with
craniofacial defects frequently show severe anomalies
of the upper limbs, craniofacial defects, constrictive
amniotic bands, and cranioplacental attachment,
whereas cases of LBWC without craniofacial defects
usually present with major anomalies of the lower
limbs, abnormal genitalia, anal atresia, renal defects,
abdominoplacental attachment, and umbilical cord
abnormalities [57,60]. The difference in the birth inci-
dence between these two groups may be due in part 
to different pathogenesis or the lethality in cases of
LBWC with craniofacial defects causing early preg-
nancy loss [57]. The pathogenetic theories concerning
LBWC include early amnion rupture [61], vascular dis-
ruption [32,53], and early embryonic maldevelopment
[62,63]. Russo et al [60] suggested that LBWC with
craniofacial defects is caused by an early vascular dis-
ruption. LBWC without craniofacial defects is related
to a defective lateral and caudal folding process of the
embryonic disk [60].
Meckel Syndrome (MKS)
MKS, also known as dysencephalia splanchnocystica,
Gruber syndrome or Meckel-Gruber syndrome, is a
lethal, autosomal recessive ciliary dysfunction disorder
characterized by occipital encephalocele, bilateral renal
cystic dysplasia, hepatic ductal proliferation, fibrosis
and cysts, and polydactyly. The worldwide incidence 
of the disease varies from 1/13,250 to 1/140,000 live
births; but in Finland, its prevalence is 1/9,000 births
[64]. MKS is genetically heterogeneous. Reported MKS
loci include MKS1 (FLJ20345; OMIM 609883) in Meckel
syndrome type 1 (MKS1; OMIM 249000) [65], MKS2
at 11q13 in MKS type 2 (MKS2; OMIM 603194) [66],
MKS3 (TMEM67; OMIM 609884) in MKS type 3
(MKS3; OMIM 607361) [67], MKS4 (CEP290; OMIM
610142) in MKS type 4 (MKS4; OMIM 611134) [68],
and MKS5 (RPGRIP1L; OMIM 610937) in MKS type 5
(MKS5; OMIM 611561) [69]. The common abnormal-
ities of MKS include occipital encephalocele, micro-
cephaly with sloping forehead, cerebral and cerebellar
hypoplasia, anencephaly, hydrocephaly with or with-
out an Arnold-Chiari malformation, absence of olfac-
tory lobes, olfactory tract, corpus callosum and septum
pellucidum, microphthalmia, cleft palate, micrognathia,
ear anomalies, a short neck, postaxial polydactyly, tali-
pes, renal dysplasia with varying degrees of cystic for-
mation, bile duct proliferation, hepatic fibrosis and
cysts, cryptorchidism, and incomplete development 
of external and/or internal genitalia [70]. Occasional
abnormalities include craniosynostosis, coloboma of
iris, hypoplastic optic nerve, hypoplastic philtrum and/
or nasal septum, hypertelorism, midline cleft lip, a lob-
ulated tongue, cleft epiglottis, neonatal teeth, a webbed
neck, relatively short-boned limbs, syndactyly, simian
creases, clinodactyly, cardiac septal defects, patent duc-
tus arteriosus, coarctation of aorta, pulmonary stenosis,
pulmonary hypoplasia, Dandy-Walker malformation,
single umbilical artery, patent urachus, omphalocele,
intestinal malrotation, spleen abnormalities, laterality
defects, adrenal hypoplasia, imperforate anus, missing
or duplicated ureters, absent or hypoplastic urinary
bladder, and enlarged placenta [70].
MKS1
Paavola et al mapped the locus for MKS to chromo-
some 17q21–q24 [71] and further narrowed down the
critical region for MKS on chromosome 17q22–q23
[72]. Kyttala et al [65] identified a gene MKS1
(FLJ20345; OMIM 609883) on 17q23 using positional
cloning. MKS1 encodes a component of flagellar appa-
ratus basal body proteome. MKS1 is 14 kb and consists
of 18 exons. MKS1 contains an open reading frame
(76–1755 base pairs) coding for a 559-amino acid
polypeptide containing a conserved B9 domain. Genes
encoding polypeptides with B9 domains, such as MKS1,
LOC80776 and EPPB9, are responsible for the flagellar
apparatus basal body proteome and are associated
with ciliary function. Cilia and flagella are ancient, evo-
lutionarily conserved organelles that project from cell
surface and serve a role in whole-cell locomotion, move-
ment of fluid, chemo-, mechano- and photosensation,
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and sexual reproduction [73]. In situ hybridization analy-
sis of Mks1, the mouse homologue of MKS1 mapping
to mouse chromosome 11, in the mouse embryo at
day 15.5 showed a prominent expression in the tissues
of bronchiolar epithelium, brain, liver, kidneys, and
digits of the upper limbs [65]. The identification of the
gene MKS1 has provided a link between MKS and cil-
iary dysfunction. Ciliary dysfunction is associated with:
(1) pronephric cyst formation and hydrocephalus in
zebrafish embryos [74]; (2) polycystic kidney disease
and Bardet-Biedl syndrome [75,76]; (3) polycystic 
kidney disease in the mouse model [77]; (4) primary
ciliary dyskinesia, polycystic liver disease, retinal degen-
eration, Alström syndrome, MKS, Joubert syndrome
(JBTS) and Senior-Loken syndrome [73]; (5) hypogo-
nadism, deafness, obesity, mental retardation, NTDs,
laterality defects and palatal clefts [78]; and (6) 
oral-facial-digital syndrome type 1 [79]. The identifi-
cation of the MKS1 gene highlights the molecular diag-
nosis of MKS and provides new insights into the role of
cilia in early embryonic development and organo- and
histogenesis.
MKS2
The MKS2 gene has yet to be identified at the time of this
writing. However, Roume et al [66] mapped the locus
for MKS to chromosome 11q13. The authors pointed
out that the D11S911–D11S906 interval encompass-
ing the gene also encompasses a gene Phox2a, which is
strongly expressed in the mouse hindbrain.
MKS3
Morgan et al [80] mapped the locus for MKS to chro-
mosome 8q24. Smith et al [67] identified a gene MKS3
(TMEM67; OMIM 609884) on 8q21.13–q22.1 by posi-
tional cloning of the Wpk gene from a rodent model,
the Wistar wpk rat. MKS3 encodes the transmembrane
protein meckelin. MKS3 spans 62,018 base pairs and
consists of 28 exons. MKS3 codes for a 995-amino
acid, seven-transmembrane receptor protein known as
meckelin. The human locus of MKS3 is syntenic to the
Wpk locus in rat, which has birth defects similar to
MKS such as polycystic kidney disease, agenesis of the
corpus callosum and hydrocephalus [81,82]. Human
and rat meckelin are 84% identical and 91% similar
[67]. Meckelin contains a signal peptide, at least two
cysteine-rich repeats, a 490-residue extracellular region
with four N-linked glycosylated sites, seven transmem-
brane domains, and a 30-residue cytoplasmic tail. The
identification of the MKS3 gene as well as the MKS1
gene enables molecular genetic testing for at-risk fami-
lies and allows for accurate genetic counseling, carrier
testing and prenatal diagnosis.
MKS4
Baala et al [68] performed a genome-wide linkage scan
in eight families unlinked to MKS1, MKS2, or MKS3 and
identified truncating mutations in CEP290 or NPHP6
(OMIM 610142) on 12q21.3 in two families with MKS
and in four families with a cerebro-reno-digital syn-
drome having a phenotype overlapping with MKS and
JBTS. Frank et al [83] identified a frameshift mutation
in CEP290 in a consanguineous family with two MKS
fetuses and suggested the pleiotropic effects of CEP290
mutations ranging from single-organ involvement 
with isolated Leber congenital amaurosis to JBTS and
lethal early embryonic multisystemic malformations in
MKS. CEP290 gene or NPHP6 encodes nephrocystin-6
(NPHP6) or 3H11Ag, which is a peripheral membrane
protein associated with the nuclear membrane [84].
Valente et al [85] detected CEP290 expression in pro-
liferating cerebellar granule populations and showed
centrosome and ciliary localization. Mutations in
CEP290 cause pleiotropic forms of JBTS [85] and
oculo-renal form of JBTS-related disorders [86].
MKS5
Delous et al [69] identified homozygous or compound
heterozygous truncating mutations in RPGRIP1L gene
(OMIM 610937) on 16q12.2 of three patients with
MKS and missense mutations in RPGRIP1L of five
patients with JBTS. Their findings suggested that muta-
tions in RPGRIP1L can cause the multiorgan phenotypic
abnormalities in MKS or JBTS. Arts et al [87] identified
homozygous or compound heterozygous mutations 
in RPGRIP1L of patients with JBTS. RPGRIP1L gene or
KIAA1005 encodes RPGRIP1L protein which is local-
ized to basal bodies and ciliary axonemes at the base of
primary cilia and is a nephrocystin-4 interactor [69,87].
Joubert Syndrome (JBTS)
JBTS (OMIM 213300) is an autosomal recessive ciliary
dysfunction disorder characterized by hypoplasia of
the cerebellar vermis with the characteristic brain stem
malformation and neuroradiologic “molar tooth
sign”, and variable features including retinal dystrophy
and renal anomalies. About a quarter of patients 
with JBTS have nephronophthisis (NPHP) and retinal
dystrophy, which is termed as cerebello-ocular-renal
syndrome or JBTS type B. NPHP consists of tubulo-
interstitial fibrosis and cysts at the corticomedullary
junction. JBTS has an incidence of 1 in 100,000 births
[88]. Reported JBTS loci include AHI1 [89], NPHP1 [90],
MKS3/TMEM67 [91], MKS4/CEP290 [92], and MKS5/
RPGRIP1L [69, 87]. JBTS4 is caused by mutations in
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the NPHP1 gene [90], JBTS5 is caused by mutations 
in the MKS4/CEP290 gene [85], JBTS6 is caused by
mutations in the MKS3/TMEM67 gene [91], and JBTS7
is caused by mutations in the MKS5/RPGRIP1L gene
[69,87]. Mutations in four genes, MKS1/FLJ20345
[65], MKS3/TMEM67 [67], MKS4/CEP290 [68] and
MKS5/RPGRIP1L [69,87], have been identified in
MKS, and mutations in MKS3/TMEM67 [91], MKS4/
CEP290 [85,86,91] and MKS5/RPGRIP1L [69,87] have
been identified in JBTS, indicating that MKS and JBTS
constitute a continuum of the same disorder. JBTS can
be associated with retinitis pigmentosa, renal polycystic
disease, polydactyly, situs inversus/isomerism, mental
retardation/developmental delay, hypoplasia of cor-
pus callosum, Dandy-Walker malformation, posterior
encephalocele, and hepatic disease [73]. Senior-Loken
syndrome (SLSN; OMIM 266900) is an autosomal
recessive ciliary dysfunction disorder caused by muta-
tions in the NPHP1 gene [93] and MKS4/CEP290 [94].
NPHP is a cystic renal disease characterized by pro-
gressive wasting of the filtering unit of the kidney with
or without medullary involvement. NPHP is associated
with mutations in the genes of NPHP1 and MKS4/
CEP290 [94]. SLSN can be associated with retinitis
pigmentosa, renal cystic disease, situs inversus/isom-
erism, Dandy-Walker malformation, and hepatic dis-
ease but does not have polydactyly and posterior
encephalocele [73]. NPHP, MKS and SLSN share JBTS
phenotypes. Among the five JBTS genes (AHI1,
NPHP1, MKS3/TMEM67, MKS4/CEP290 and MKS5/
RPGRIP1L), three genes (MKS3/TMEM67, MKS4/
CEP290 and MKS5/RPGRIP1L) are also associated
with MKS, and two genes (NPHP1 and MKS4/CEP290)
are also associated with SLSN and NPHP, indicating
genetic complexity in JBTS and related disorders [88].
Skeletal Dysplasia
NTDs may occasionally be observed in cases of skele-
tal dysplasia. Bronshtein and Weiner [95] reported the
prenatal diagnosis of osteogenesis imperfecta with
anencephaly in a fetus at 14 weeks’ gestation by trans-
vaginal sonography. Ruano et al [96] reported the pre-
natal diagnosis of osteogenesis imperfecta with
anencephaly in a fetus at 13 weeks’ gestation using
conventional and three-dimensional ultrasound. Jap-
A-Joe et al [97] reported thanatophoric dysplasia type
2 with encephalocele and aortic hypoplasia in an
anatomic specimen of the Museum Vrolik collection 
of the Department of Anatomy and Embryology at the
University of Amsterdam. Li et al [98] reported the
second-trimester diagnosis of thanatophoric dysplasia
type 2 with encephalocele. Malguria et al [99] reported
the prenatal detection of MKS, encephalocele, polycys-
tic kidneys and symmetrical short-limbed dwarfism.
Chen et al [100] reported a case of achondrogenesis
type IA with occipital encephalocele.
Diabetic Embryopathy
Reece [101,102] has summarized the oxidative stress
model of diabetic embryopathy as follows: (1) hyper-
glycemia increases the levels of free radicals and the
production of reactive species, causing oxidative stress;
and (2) oxidative stress increases the levels of apoptosis-
inducing signaling molecules and simultaneously
decreases the levels of molecules that are protective of
the cell, leading to cell suicide or apoptosis. Pampfer
et al [103] reported increase in the activity of apop-
totic pathways and increased cell death in the mouse
blastocysts exposed to high glucose in utero or tumor
necrosis factor-α in vitro. Reece [104] hypothesized
that hyperglycemia results in the excess production of
reactive oxygen species which lead to oxidative stress.
Dhanasekaran et al [105] hypothesized that signaling
pathways play a critical role in diabetic embryopathy.
Reece et al [106] noted that hyperglycemia in mater-
nal diabetes triggered oxidative stress, which enhanced
apoptotic signaling pathways and inhibited cell survival
pathways, leading to diabetes-induced embryopathy.
In that study by Reece et al, hyperglycemia induced
disruption of cellular apoptotic signaling pathways with
findings of a significantly decreased level of the cell
survival factor, phosphorylated Akt, and an increased
level of the proapoptotic protein Bax. Gäreskog et al
[107] found that supplementation of N-acetylcysteine,
an apoptosis inhibitor, ameliorated diabetes-induced
birth defects. Reece et al [108] reported that dietary
vitamin and lipid therapy rescued aberrant signaling
and apoptosis, and prevented hyperglycemia-induced
diabetic embryopathy in mice. Using DNA microarray
analysis, Reece et al [109] determined the develop-
mental genes and molecular pathways involved in dia-
betic embryopathy, such as those in insulin signaling
stress response (insulin 2, insulin-binding protein 1,
GSTπ1), cell growth (GAP43, CSF1R, HGF), and cal-
cium signaling (calbindin-3, CBPA6) and PKC signal-
ing (PKCBPβ15, FABP5). Yang et al [110,111] found
that activation of the kinase c-Jun N-terminal kinases
(JNKs), the most prominent mediator of oxidative
stress-induced apoptosis, mediated the deleterious
effect of hyperglycemia on yolk sac vasculature and
embryonic development. In the mouse model of dia-
betic embryopathy, Yang et al [112] found that there
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were activation of mediators of oxidative stress-induced
apoptosis, such as JNKs and P66Shc, and increase of
apoptotic markers.
Single Nucleotide Polymorphisms (SNPs)
in Genes of Glucose Metabolism
Genes of glucose metabolism have been suggested to be
associated with impaired development and deformities
that are similar to diabetic embryopathy in mice [113]
and in humans [114]. Heilig et al [113] reported that
isolated glucose transporter 1 (GLUT1) suppression in
mice impaired embryonic development, leading to
developmental malformations that were similar to dia-
betic embryopathy. In the study of Heilig et al [113],
the appearance of apoptosis in the GLUT1-deficient
mouse embryos suggested that GLUT1 deficiency may
play a role in producing embryonic malformations
resulting from the hyperglycemia of maternal diabetes
mellitus. Davidson et al [114] found three SNPs in the
three glucose metabolism genes, GLUT1, HK1 and LEPR,
to be associated with spina bifida in humans. GLUT1,
HK1 and LEPR are responsible for the respective pro-
teins, glucose transporter 1 (GLUT1), hexokinase 1
(HK1) and leptin receptor (LEPR), which are key sig-
naling intermediates in the glucose transporter path-
way, the hexokinase pathway and the leptin pathway,
respectively. GLUT1 is essential for human brain devel-
opment and function. GLUT1 deficiency results in
aberrant brain organogenesis and apoptosis during
embryonic development in zebrafish embryos [115].
The glycolytic enzyme HK1 binds mitochondria with
high affinity at outer mitochondrial membrane and
changes in outer mitochondrial membrane permeabil-
ity leads to apoptosis. Majewski et al [116] found that
Akt inhibited apoptosis by maintenance of hexokinase–
mitochondria interaction. Leptin actions are delivered
through the Ob (leptin) receptor, and leptin inhibits
apoptosis through several intracellular signaling path-
ways [117]. SNPs on GLUT1, HK1 and LEPR may result
in functionally inactive or dominant negative proteins
that blunt the prosurvival functions, leading to apo-
ptosis and increased susceptibility to spina bifida
[101,114].
Conclusion
This article provides a comprehensive review of syn-
dromes, disorders, and maternal and fetal risk factors
associated with NTDs, such as omphalocele, OEIS
complex, pentalogy of Cantrell, ABS, LBWC, Meckel
syndrome, JBTS, skeletal dysplasia, diabetic embryopa-
thy, and SNPs in genes of glucose metabolism. NTDs
associated with syndromes, disorders, and maternal
and fetal risk factors are a rare but important cause 
of NTDs. The recurrence risk and the preventive effect
of maternal folic acid intake in NTDs associated with
syndromes, disorders, and maternal and fetal risk fac-
tors may be different from those of nonsyndromic
multifactorial NTDs. Perinatal identification of NTDs
should alert the clinician to the syndromes, disorders,
and maternal and fetal risk factors associated with
NTDs, and prompt a thorough etiologic investigation
and genetic counseling.
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